An Analysis of Adequacy of Indian Drugs Regulatory Provisions in Combating the Problem of Spurious and Adulterated Drugs
1, 2, 3
- 1DInspector of Drugs, Directorate, Drugs Control, Government of Jharkhand
- 2Associate Professor, B.I.T. Mesra, Ranchi
- 3Professor Emeritus, Department of Pharmaceutical Sciences, Nagpur University
CORRESPONDENCE
D. Ramya Devi
Asst. Prof. Department of Pharmacy, School of Chemical and Biotechnology, SASTRA University, Thanjavur - 613401 Tamil Nadu, India.
Received: 10-10-2011; Accepted: 26-01-2012.
Volume 46, Issue 3 · pp. 290-295 · 2012 · DOI:
ABSTRACT
In 2003, Mashelkar committee found that 10% of available drugs in India are Sub- standard. Recently (June 2011) Honorable Apex Court of India observed that the Drugs Act of India does not has deterrence. It has to be analyzed that whether mere enhancing the punishment under the Act shall make it deterrent. It has to be find out what other changes in the Act is required to make it more effective. Drugs Control Authorities need power of interrogation and power to ask a person to make statement. These powers shall help them to gather evidence against the culprit and these powers shall enable them to conclude the investigation to a logical end.
KEYWORDS
REFERENCES
As publishedShowing references and in-text citations exactly as published.
Cite this article
SELECT FORMAT
Das, B., R.N., G., & Dorle, A. (2012). An Analysis of Adequacy of Indian Drugs Regulatory Provisions in Combating the Problem of Spurious and Adulterated Drugs. Indian Journal of Pharmaceutical Education and Research, 46(3), 290-295.
Copyright and licence
© 2012 Author(s)
This is an open access article distributed under the terms of the Creative Commons Attribution 4.0 License, which permits unrestricted use, distribution and reproduction in any medium, provided the original author and source are credited. CC BY 4.0